Original language | English |
---|---|
Journal | Diabetes Therapy |
Volume | 3 |
Issue number | 1 |
Pages (from-to) | 10 |
ISSN | 1869-6953 |
DOIs | |
Publication status | Published - 2012 |
Linagliptin, a selective DPP-4 inhibitor, inhibits DPP-4, increases incretin levels, lowers glucagon, and improves glycaemic control in patients with Type 2 diabetes.
T Rauch, U Graefe-Mody, Carolyn F. Deacon, A Ring, Jens Juul Holst, H-J Woerle, KA Dugi, T Heise
Research output: Contribution to journal › Journal article › Research › peer-review
46
Citations
(Scopus)